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Abstract
Sphingosine-1-phosphate (S1P), a lipid second messenger formed upon phosphorylation of 
sphingosine by sphingosine kinase (SK), plays a crucial role in natural killer (NK) cell 
proliferation, migration, and cytotoxicity. Dysregulation of the S1P pathway has been linked to a 
number of immune system disorders and therapeutic manipulation of the pathway has been 
proposed as a method of disease intervention. However, peripheral blood NK cells, as identified 
by surface markers (CD56+CD45+CD3−CD16) consist of a highly diverse population with distinct 
phenotypes and functions and it is unknown whether the S1P pathway is similarly diverse across 
peripheral blood NK cells. In this work, we measured the phosphorylation of sphingosine–
fluorescein (SF) and subsequent metabolism of S1P fluorescein (S1PF) to form hexadecanoic acid 
fluorescein (HAF) in 111 single NK cells obtained from the peripheral blood of four healthy 
human subjects. The percentage of SF converted to S1PF or HAF was highly variable amongst the 
cells ranging from 0% to 100% (S1PF) and 0% to 97% (HAF). Subpopulations of cells with 
varying levels of S1PF formation and metabolism were readily identified. Across all subjects, the 
average percentage of SF converted to S1PF or HAF was 37 ± 36% and 12 ± 19%, respectively. 
NK cell metabolism of SF by the different subjects was also distinct with hierarchical clustering 
suggesting two possible phenotypes: low (<20%) or high (>50%) producers of S1PF. The 
heterogeneity of SK and downstream enzyme activity in NK cells may enable NK cells to respond 
effectively to a diverse array of pathogens as well as incipient tumor cells. NK cells from two 
subjects were also loaded with S1PF to assess the activity of S1P phosphatase (S1PP), which 
converts S1P to sphingosine. No NK cells (n = 41) formed sphingosine, suggesting that S1PP was 
minimally active in peripheral blood NK cells. In contrast to the SK activity, S1PP activity was 
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homogeneous across the peripheral blood NK cells, suggesting a bias in the SK pathway towards 
proliferation and migration, activities supported by S1P.
Introduction
Natural killer (NK) cells are effector lymphocytes that play a vital role in the immune 
response. NK cells can rapidly attack tumor cells and pathogen-infected cells in the absence 
of antigen-specific cell surface receptors.1 To accomplish this task, NK cells express major 
histocompatibility complex (MHC) class 1-specific inhibitory receptors, which enable them 
to recognize “self” markers. Upon interaction with foreign or stressed cells missing “self” 
markers, NK cells lose these inhibitory signals and become activated, releasing cytotoxic 
granules to lyse or initiate apoptosis in target cells. NK cells also express activating 
receptors, such as natural killer group 2, member D (NKG2D), which recognize ligands 
overexpressed in distressed or damaged cells.2 Additionally, NK cells are major producers 
of proinflammatory and immunosuppressive cytokines, such as tumor necrosis factor α 
(TNF-α) and interleukein-10 (IL-10), respectively.3 NK cells are typically grouped into two 
major subsets, CD56bright and CD56dim cells.4 CD56bright cells represent up to 10% of NK 
cells in peripheral blood, and are generally weakly cytotoxic but highly active cytokine 
producers.5 The remaining 90% of peripheral blood NK cells are CD56dim and are more 
efficient at lysing target cells but poor producers of cytokines. A recent study employing 
mass cytometry to characterize 36 cell surface proteins in NK cells, revealed extraordinary 
phenotypic heterogeneity amongst primary NK cells.6 The level of inhibitory receptor 
expression was primarily determined by genetics, while the expression level of activating 
receptors was heavily influenced by the environment. Based on these results, NK cells were 
proposed to consist of 6000 to 30 000 distinct subsets in the peripheral blood of a single 
person.7 This extreme level of heterogeneity suggests that each NK cell is likely unique and 
that technologies capable of single-cell measurements are vital to characterizing the 
physiology and function of NK cells.
The sphingosine-1-phosphate (S1P) pathway is a key regulator of lymphocyte migration, 
differentiation, and cytokine production.8-10 Sphingosine and S1P are interconverted by the 
actions of sphingosine kinase (SK) and S1P phosphatase (S1PP).11 Sphingosine can also be 
acetylated by ceramide synthase (CerS) to form ceramide, while S1P is also degraded by 
S1P lyase (S1PL) to form hexadecenal and ethanolamine phosphate. The relative amounts of 
these sphingolipids have been shown to determine cell fate i.e. death or survival.12 S1P 
drives lymphocyte proliferation, differentiation, egress through blood-vessels, and 
production of pro-inflammatory cytokines. Increases in sphingosine and ceramide typically 
act in opposition to S1P and promote inflammation, apoptosis, and autophagy.13 
Dysregulation of the S1P pathway has been linked to a number of diseases of the immune 
system, including asthma, rheumatoid arthritis, and inflammatory bowel disease. The S1P 
pathway is particularly important for regulating NK cell migration and cytotoxicity. 
Gradients of S1P drive NK cell chemotaxis, and S1PR5, a member of the S1P receptor 
(S1PR) family, is essential for the mobilization of NK cells to inflamed organs.14 Despite 
promoting increased NK cell mobility, S1P also inhibits NK cell cytotoxicity.15 Conversely, 
glycosylated ceramides enhance NK cell cytotoxicity.16 The intracellular balance of these 
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sphingolipids within single NK cells has not yet been measured, leading to significant gaps 
in understanding how the competing roles of these lipids are managed within a single cell 
and across a population of cells.
Although single-cell measurements are important for characterizing cellular diversity in NK 
cells, developing technologies capable of directly measuring lipid signaling in single 
primary cells has proven extremely challenging. These cells are fragile with high death rates 
in response to extensive handling and difficult to load with exogenous reagents. Their very 
small (6–7 μm diameter) size also requires analytical methods with very low limits of 
detection (LODs). Antibodies directed against lipids, including S1P, have been used to label 
cells from primary samples; however, these antibodies are plagued by nonspecific binding.17 
The poor immunogenicity of most lipids also limits the affinity of the antibodies for their 
targets.18
Further, most antibody-based assays are indirect, qualitative measures of signaling processes 
since they detect only substrate or only product and do not quantify the number of moles of 
these species present in a cell. Characterization of multiple elements in a signaling pathway 
e.g. substrate, product and metabolites, is often required to achieve an accurate view of 
pathway signaling. Fluorescently and radiometrically-labeled sphingosines have been 
developed for monitoring SK activity in assays using lysates or purified enzyme but rarely 
used for measurements on single cells.19-21 To distinguish sphingosine from S1P, these 
assays incorporate an environment-sensitive fluorophore such as nitrobenzoxadiazole or 
utilize [32P]ATP. In these assays, an additional separation step thin-layer chromatography 
(TLC)19 or high performance liquid chromatography (HPLC)22 is required to remove 
unmetabolized ATP or to separate sphingosine from S1P. This increases assay complexity 
and nonspecific loss of the lipids. Analysis of sphingosine and S1P is also frequently 
accomplished using HPLC followed by mass spectrometry (MS) which permits detection of 
other sphingolipids but at a cost of poor sensitivity and therefore large sample sizes.23 None 
of the above technologies meet the requirements necessary for single-cell assays of 
sphingosine and its metabolites, i.e. ultra-high sensitivity, quantification of substrate and 
product simultaneously, and the ability to detect additional metabolites.
Capillary electrophoresis (CE) is well suited for separating the components of very small 
samples, routinely achieving subattomole limits of detection and yielding highly efficient 
separations of metabolites, often up to 1 million theoretical plates. With inclusion of internal 
standards, CE is capable of highly accurate quantification of molecules, including that 
obtained from a single-cell. The analysis of single cells by CE or chemical cytometry has 
been applied to measure a wide range of biological attributes including enzymatic activities 
such as kinases, lipases, and phosphatases.24-26 CE has been utilized to measure sphingosine 
kinase activity in cell lysates by separating fluorescently-labeled sphingosine and 
sphingosine-1-phosphate.27 Previously, an automated CE system was employed to rapidly 
quantify the conversion of a fluorescent sphingosine reporter (SF) to fluorescent S1P (S1PF) 
in single cells.28 The technology also detected the presence of additional metabolites of SF 
and S1PF, although these were not identified. The automated single-cell CE system 
increased throughput 100-fold compared to that attained by non-automated systems, 
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permitting the analysis of sufficiently large sample sizes to identify statistically significant 
differences of S1P pathway signaling.
This work describes the use of automated single-cell CE system to characterize the S1P 
pathway in single primary human NK cells from peripheral blood. The conversion of SF to 
S1PF was measured in NK cells from four healthy subjects. The metabolism of S1PF to 
hexadecanoic acid fluorescein (HAF) was also characterized. The relative activities of SK 
and S1PP were assayed in the NK cells of two subjects by comparing cells loaded with SF to 
cells loaded with S1PF. The heterogeneity in S1P pathway activity was quantified amongst 
cells from a single subject as well as between different subjects. Measuring the single-cell 




Sphingosine 5/6-fluorescein (SF) and sphingosine-1-phosphate 5/6-fluorescein (S1PF) were 
procured from Echelon Biosciences Inc. (Salt Lake City, UT). Monosodium phosphate, 1-
propanol, isopropanol, methanol, and pre-cleaned glass slides (50 mm × 45 mm × 1.5 mm) 
were acquired from Fisher Scientific (Pittsburgh, PA). Sodium chloride, sodium azide, 
potassium chloride, paraformaldehyde, magnesium chloride, calcium chloride, piperazine-1-
ethanesulfonic acid (HEPES), formic acid, and glucose were purchased from Sigma-Aldrich 
Inc. (St Louis, MO). Ethanol was procured from Decon Labs (King of Prussia, PA). Roswell 
Park Memorial Institute Media (RPMI) with L-glutamine, fetal bovine serum (FBS), 
Dulbecco’s phosphate buffered saline, and penicillin/streptomycin were purchased from 
Invitrogen (Grand Island, NY). EPON resin 1002F (phenol, 4,4′-(1-methylethylidene)bis-, 
polymer with 2,2′-[(1-methylethylidene)-bis(4,1-phenyleneoxymethylene)]bis-[oxirane]) 
was acquired from Miller–Stephenson (Sylmar, CA, USA). SU-8 developer (1-methoxy-2-
propyl acetate) was purchased from MicroChem (Newton, MA, USA). 
Poly(dimethylsiloxane) (PDMS) (Sylgard 184 Silicone Elastomer) was procured from Dow 
Corning (Midland, MI). Acetonitrile was purchased from VWR (Radnor, PA).
Purification of natural killer cells from PBMCs
Blood was drawn from study participants using a protocol approved by the University of 
North Carolina Institutional Review Board for Biomedical Research. Written consent was 
provided by each study participant. PBMCs were isolated using a Lymphoprep gradient 
(Axis Shield, Scotland, UK), similar to that used in previous studies.29-31 NK cells were 
isolated from PBMCs by negative selection using Dynabeads NK isolation kit (Invitrogen, 
Carlsbad, CA), which depletes T cells, B cells, monocytes, platelets, dendritic cells, 
granulocytes, and erythrocytes using monoclonal antibodies directed against CD3, CD14, 
CD36, HLC Class II, CD123, and CD235a. After isolation, the NK cells were suspended in 
media (RMPI 1640 with L-glutamine, 10% heatinactivated FBS, and 1% penicillin/
streptomycin) for single-cell analysis or flow buffer (1% heat-inactivated FBS and 0.09% 
sodium azide in Dulbecco’s phosphate buffered saline without magnesium or calcium) for 
flow cytometry analysis.
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Flow cytometry characterization of NK cell purity was conducted by incubating NK cells 
with antibodies directed against CD45-allophycocyanin cyanine 7 (APCCy7) (BD 
Biosciences, San Jose, CA), CD56-phycoerythrin (PE) (BD Biosciences), CD3-
allophycocyanin (APC) (BD Biosciences), and CD16-Pacific Blue (BD Biosciences), as in 
previous studies.29-31 The cells were fixed in 0.5% paraformaldehyde, and analyzed within 
24 hours of fixation by flow cytometer (BD LSRII, BD Biosciences). Data were analyzed 
with FLOWJO (TreeStar, Ashland, OR). Dead cells were excluded using a LIVE/DEAD® 
fixable far-red viability dye (Molecular Probes, Grand Island, NY). The purity of the NK 
cell preparation was quantified by flow cytometric measurement of CD45 and CD56 protein 
expression (CD45+CD56+). The population was comprised of 92 ± 4% CD45+CD56+ cells 
which define NK cells (Fig. S1, ESI†). This was comparable to previously published NK 
cell purifications using this method.29-31 The absence of cells stained with anti-CD3-APC 
antibodies indicated that there were no contaminating T cells.
Fabrication of microwells
The arrays of 10 × 10 microwell cell traps were fabricated by patterning holes into a 
photoresist layer on a coverslip using standard photolithography as described previously.28 
Briefly, coverslips were spin-coated with 1002F photoresist, and baked at 95 °C for 30 
min.32 An iron oxide photomask was then placed above the 1002F-coated coverslip and the 
assembly illuminated with UV light (600 mJ). The photoresist-coated coverslip was 
subsequently developed in SU-8 developer, rinsed with isopropanol, and then baked at 120 
°C for 30 min. The microwells or cell traps were 20 μm in depth and separated from 
adjacent wells by 100 μm.
Fabrication of poly(dimethylsiloxane) channel system
The PDMS channel system used to store the captured cells in a physiologic buffer solution 
as well as to contain the electrophoretic buffer for CE separations was similar to that 
described previously.28 A PDMS layer with cutouts for the physiologic and electrophoretic-
buffer channels was bonded to the microwell array. The electrophoretic-buffer channel was 
parallel to the physiologic buffer-channel. These buffer channels were connected by a 
perpendicular channel filled with air. The electrophoretic and physiologic buffers remained 
in their respective channels due to surface tension. The cell trap array was placed in the 
physiologic buffer channel aligned with the center of the air-channel.
Reporter loading
For single-cell experiments, SF and S1PF were loaded into cells by incubating 5 × 105 cells 
in 100 μL NK cell media containing 80 μM SF or S1PF for 30 min at 37 °C in a 5% carbon 
dioxide atmosphere. For cell lysate experiments, cells were incubated with 10 μM SF for 1 
h. After reporter loading, cells were pelleted and then washed 5 times with 200 μL 
physiologic buffer (135 mM sodium chloride, 5 mM potassium chloride, 1 mM magnesium 
chloride, 1 mM calcium chloride, 10 mM HEPES, and 10 mM glucose at pH 7.4). For 
single-cell experiments, cells were then resuspended in physiologic buffer at a concentration 
†Electronic supplementary information (ESI) available. See DOI: 10.1039/c5ib00007f.
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of 1 × 104 cells per μL and immediately loaded into cell traps. The sum of the 30 min 
incubation time with the reporter and the additional waiting time before cell lysis is termed 
the “reporter exposure time”. For cell lysate experiments, cells were resuspended in 10 μL of 
physiologic buffer and then chemically lysed by adding 10 μL of methanol. Cell lysates 
were immediately stored at −80 °C until analysis. Statistical differences in reporter loading 
with SF vs. S1PF were calculated using a Mann–Whitney U-test.33
Ensemble measurements of the sphingosine kinase pathway using cell lysates
Two types of cells were used to perform analysis of the S1P pathway in cell lysates: NK 
cells from peripheral blood and tissue-cultured K562 cells originally derived from a chronic 
myelogenous leukemia patient. Conversion of SF to S1PF was measured in both cell types 
by loading cells with reporter, as described above, lysing the cells, and separating the 
fluorescent compounds using CE. For experiments testing the effect of SK inhibition, K562 
cells were incubated in media (RMPI 1640 with L-glutamine, 10% heat-inactivated FBS, and 
1% penicillin/streptomycin) with varying concentrations of SK Inhibitor 2 (SKI 2) (Cayman 
Chemical Co., Ann Arbor, MI) for 30 min.34 SF reporter was then added to this media, as 
detailed above, and phosphorylation of the reporter was quantified. The cells were therefore 
exposed to SKI 2 for a total period of 1.5 h. In order to test the effects of ceramide synthase 
inhibition, K562 cells were incubated with 10 μM fumonisin B1 (Sigma-Aldrich), a 
ceramide synthase inhibitor, for 2 h.35 Cells were then loaded with the reporter, lysed, and 
analyzed using CE. Cells were exposed to fumonisin B1 for a total of 3 h. In order to 
generate lysates for HPLC-MS analysis, 10 million K562 cells were incubated with 80 μM 
SF for 1 h, washed as described above, resuspended in 50 μL of ECB, and lysed by the 
addition of 50 μL of methanol. The cell suspension was then filtered to remove debris prior 
to HPLC analysis.
Characterizing lysates using HPLC-MS
Analysis of SF and its metabolites were performed with an HPLC-MS system consisting of 
an Agilent 1200 HPLC and Agilent 6520 Accurate Mass Quadruple Time-Of-Flight (Q-
TOF) mass spectrometer (Agilent Technologies, Milford, MA). Gradient separations were 
performed using a 2.1 mm × 50 mm Agilent Eclipse XDB-C18 column with 1.8 mm 
particles. Separations were conducted for a total of 12 minutes at a flow rate of 0.2 mL 
min−1 and a pressure of 400 bar. The mobile phase composition was 30% acetonitrile and 
0.1% formic acid for 1.5 min followed by a linear increase to 90% acetonitrile and 0.1% 
formic acid over 7.5min, and then 90% acetonitrile and 0.1% formic acid for 3 min. 
Negative mode electrospray ionization (ESI) MS was conducted with a fragmentor voltage 
of 200 V, nebulizing gas pressure of 45 psi, and a capillary voltage of 3500 V. Sample (35 
μL) was used for each separation. Fractions of HPLC eluent were collected manually for 
subsequent CE analysis. Data analysis was performed using Agilent Qualitative Analysis B.
04.00 software.
Cell capture in microwells
SF or S1PF-loaded NK cells were captured in microwells by pipetting 10 μL of cells (1 × 
106 cells per mL) onto the microwell array. The cells were incubated on the array for 20 
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min, and then excess cells were rinsed from the array with physiologic buffer. The cells 
trapped in the wells were then continually bathed in physiologic buffer at 35 °C (1 mm s−1 
flow velocity). A student t-test was used to compare the capture efficiency of microwells 
with different diameters.
Automation of single-cell analysis
The PDMS channel system was mounted on an inverted microscope (Ti-E, Nikon, Melville, 
NY) with a computer-controlled motorized stage (Ti-SER, Nikon). The microscope stage 
was fitted with a temperature controlled stage insert. The insert was maintained at 37 °C for 
the duration of the experiment. Customized software (Python, Wolfeboro Falls, NH and 
Micro-Manager, Vale Lab, UCSF) identified the address of each cell trap and moved the 
motorized stage.28 Each cell trap that did not contain a single cell was manually deleted 
from the program’s list of well addresses to be interrogated, so that only wells with single-
cells were analyzed. All other tasks were performed using LabVIEW (National Instruments, 
Austin, TX).
Measurement of sphingosine kinase activity in single cells
During automated single-cell analysis, the following events occurred sequentially under 
computer control. The microscope stage moved to the address of the first cell to be analyzed, 
placing the cell directly below the inlet of a capillary (30 μm i.d.). The capillary was aligned 
50 μm above the plane of the microwells. A focused laser pulse lysed the cell by creating a 
cavitation bubble36 and the cell’s contents were then electrokinetically loaded into the 
capillary. Electrokinetic injections were performed by the application of 5 kV across the 
capillary for 1 s. The voltage was then set to zero as the stage moved through the air channel 
to the center of the electrophoretic buffer channel. A voltage of 18 kV (0.5 kV cm−1) was 
applied across the capillary for 55 ± 10 s to separate the cellular contents. The voltage was 
then set to zero for 1 s as the stage moved back to place the capillary at the address of the 
next cell to be assayed. The next cell was lysed, then injected, and this entire process was 
repeated until all of the cells in the array were analyzed.
The capillary was interrogated 4 cm from the inlet end by the focused beam of a fiber-
coupled diode pumped solid state 473 nm laser and the fluorescence of the analytes detected 
with a photomultiplier tube as described previously.37 The analytes were identified by 
comparison of their migration times to that of standards. The peak areas of SF, S1PF, and 
unidentified compounds were calculated using a custom program written in MATLAB 
(Natick, MA).38 The peak areas of known amounts of SF and S1PF standards were used to 
calculate the molar amount of SF and S1PF contained in each cell. A brightfield image of 
each cell, taken immediately prior to the single-cell experiment, was used to measure cell 
diameter.
In order to characterize the activity of S1P pathway enzymes, the molar amounts of SF, 
S1PF, and HAF in each cell were calculated using a calibration curve. The total reporter 
loaded per cell was defined as the sum of the number of moles of SF, S1PF, and HAF 
(SFmol + S1PFmol + HAFmol). The percent of each compound was calculated by dividing the 
molar amount of the compound by the total moles of reporter loaded into cells. For instance, 
Dickinson et al. Page 7













the percent of S1PF formed was calculated as S1PFmol/(SFmol + S1PFmol + HAFmol). The 
“reporter exposure time” for each cell was defined as the time between the start of the cell 
incubation with SF or S1PF and the time of cell lysis.
Statistical analysis
Linear regressions were performed to determine coefficients of determination (R2). A t test 
was used to determine whether correlations were statistically significant.39 Hierarchical 
clustering was performed using a cosine distance function to compare the total distribution 
of percent S1PF between the four subjects.40
Results and discussion
Optimization of the automated CE system for NK cell analysis
The S1P pathway in NK cells was characterized using an automated CE system comprised 
of a three-channel microdevice mounted on an automated microscope operated with 
customized software (Fig. 1a).28 Two parallel channels, one containing electrophoretic 
buffer and the other a physiologic buffer, were connected by a perpendicular air-filled 
channel. Surface tension forces at the air-buffer interfaces prevented the electrophoretic and 
physiologic buffers from mixing. This three-channel design enabled fast transfer of the 
capillary between physiologic and electrophoretic buffers with minimal carryover of the 
buffers. Individual cells were captured in the physiologic buffer channel within cell traps, or 
microwells, microfabricated into the lower surface of the channel (Fig. 1b and c). The 
capillary moved under software control to the address of an initial cell trap, after which the 
cell beneath the capillary was lysed using a laser pulse,36 and the cellular contents 
electrokinetically injected into the capillary. The capillary traversed through the air channel 
to the electrophoretic buffer and separation of the cell contents was initiated. After a defined 
time, the capillary moved back through the air gap to a position above the next cell to be 
analyzed and the entire process was repeated in a fully automated fashion.
In order to efficiently trap NK cells, which are small (6–7 μm diameter) relative to the size 
of most tissue-cultured cells (12–15 μm diameter), the cell-trap size was optimized for 
capture of single NK cells. Microwells (20 μm deep) with 4 different diameters (15, 20, 25, 
and 30 μm) were tested for their single-cell capture efficiency. NK cells were loaded onto 
the microwell array and permitted to settle by gravity. The array was then washed to remove 
the excess cells. The 15 μm microwells were significantly more effective at trapping single 
NK cells than the 20, 25, and 30 μm diameter wells (Fig. 1d). The percentages of microwells 
that captured more than one primary cell were 13 ± 13%, 22 ± 5%, 80 ± 20%, and 63 ± 6% 
for the 15, 20, 25, and 30 μm microwells, respectively. These results are consistent with 
previous work suggesting that microwells that are double the cell size aremost efficient at 
single-cell capture.37 Due to their higher efficiency at capturing single cells, cell traps with 
diameters of 15 μm were used to capture cells for all subsequent single-cell CE assays.
Assay of S1P signaling in single cells by CE
NK cells were incubated with the SF reporter and then loaded into microwell traps (Fig. S2a, 
ESI†). Traps with zero cells or >2 cells were not utilized in the assays. The diameter of each 
Dickinson et al. Page 8













trapped, single cell was measured by brightfield microscopy and used to estimate cell 
volume. The cells were then sequentially analyzed using the automated, single-cell CE 
system(Fig. S2b, ESI†). Three major peaks were observed from the cells on the 
electropherograms (Fig. 2a and b). Two of the peaks were identified as SF and S1PF based 
on their co-migration with standards. A third peak was observed in a subpopulation of cells. 
This peak, which had an unknown identity, was named Unknown 50 (U50) since it migrated 
at 50 s. U50 has previously been reported to be an unidentified fluorescein-labeled 
metabolite of the S1P pathway (Fig. 2c).
To determine the identity of U50, K562 cells, which have previously been shown to form 
relatively large amounts of U50, were treated with inhibitors of S1P pathway enzymes.25 
Inhibition of ceramide synthase by fumonisin B1 did not affect the production of U50 in cells 
(Fig. S3, ESI†). However, inhibition of SK by sphingosine kinase inhibitor 2 (SKI 2) was 
found to decrease formation of U50 as well as the production of S1PF (Fig. S4a, ESI†). In 
addition, increasing concentrations of SKI 2 decreased U50 formation in a dose-dependent 
manner (Fig. S4b, ESI†). These results suggested that U50 might be a metabolite 
downstream of S1PF. To identify U50, K562 cells were loaded with SF, incubated, lysed and 
the lysate separated using HPLC (Fig. S5a, ESI†). The mass of all fluorescent species was 
measured using mass spectrometry. Three fluorescent sphingolipids were identified: SF, 
S1PF, and an analyte with a mass (627.29) matching that of hexadecenoic acid fluorescein 
(HAF). Although no hexadecenal–fluorescein was observed, hexadecenal is rapidly 
converted to hexadecanoic acid by fatty aldehyde dehydrogenase (FALDH) in cells.41 These 
data suggested that hexadecenal–fluorescein was produced in the cells but rapidly converted 
to HAF by FALDH. To confirm the identity of the species with molecular weight 627.29 as 
HAF, MS–MS was performed. Species with molecular weights consistent with HAF with 
CO2 and/or water loss were identified confirming the presence of HAF in the cell lysate 
(Fig. S5b, ESI†). To determine whether U50 was indeed HAF, a fraction of the HPLC eluent 
containing HAF was collected and then electrophoresed. HAF possessed a migration time of 
50 s and co-migrated with U50 when co-injected (Fig. S5c, ESI†). Thus, U50 is HAF, a 
downstream metabolite of S1PF.
Characterization of reporter exposure time and cell size on S1PF formation
NK cells from 4 healthy subjects were loaded with SF, placed in cell traps, and analyzed SF 
metabolites measured. In total, 133 cells (49, 32, 31, and 21 cells from subjects 1, 2, 3, and 
4, respectively) were examined. The electropherograms from 14 ± 13% of the cells (32%, 
7%, 35%, and 0% from subjects 1, 2, 3, and 4, respectively) did not contain fluorescent 
peaks above the limit of detection i.e. a peak height greater than or equal to three times the 
standard deviation of the background, suggesting that an insufficient amount of SF was 
loaded into these cells for detection (Fig. S6a and b, ESI†). Of the 111 cells with detectable 
peaks, the total amount of SF loaded per cell ranged from 0 to 196 amol, corresponding to 
0–2.2 mM, assuming that the cells were spherical (6 μm diameter). Only the 111 cells with 
identifiable fluorescent peaks were further characterized. Within these 111 cells, there was 
no correlation between the total amount of reporter loaded per cell (R2 = 0.009), the cell 
diameter (R2 = 0.009, Fig. S7, ESI†) or the reporter exposure time (R2 = 0.02). The absence 
of a correlation between the total amount of loaded reporter in a cell and the cell diameter 
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suggests that each cell possessed a different intracellular concentration of the reporter. The 
lack of correlation between the total amount of loaded reporter in a cell and the reporter 
exposure time suggested that significant amounts of reporter were not exported from the 
cells over time. There was additionally no correlation between the amount of moles of S1PF 
produced and the reporter exposure time (R2 = 0.01) for the combined cells from all subjects 
(Fig. S8a and b, ESI†). This lack of a correlation may be due to the formation of an 
equilibrium between the substrate, SF, and product, S1PF, within the cell. The number of 
moles of S1PF produced did increase with the total amount of reporter loaded into cells (R2 
= 0.9, p ≤ 0.001, Fig. S9, ESI†). This relationship remained linear, even at very high 
amounts of loaded reporter, indicating that SK was not saturated in many of the cells. A 
significant fraction of cells (5% and 22%) from subjects 1 and 3, respectively, fully 
converted the SF reporter to S1PF even in cells with as much as 28 amol of total reporter. In 
some cells, over 98% of the SF reporter was converted despite extremely high quantities of 
loaded reporter 196 amol or approximately 2 mM demonstrating an exceptionally high 
capacity to produce S1P.
S1PF and HAF formation in single primary NK cells
The conversion of the reporter to S1PF and HAF was highly variable amongst individual 
NK cells (Fig. 3a). On average, the electropherograms of 70 ± 16% and 30 ± 10% of cells 
possessed identifiable S1PF or HAF, respectively. The average percent of reporter converted 
to S1PF or HAF was 37 ± 36% and 12 ± 19%, respectively, across all cells from all subjects. 
There was no correlation between % HAF formation and the total amount of reporter loaded 
into cells (R2 = 0.002), suggesting that the amount of HAF formed was not dependent on 
reporter uptake. In general, the percentage of SF converted to HAF was less than that 
converted to S1PF. Only 9 of 111 cells formed a greater amount of HAF than S1PF. This 
suggested that once formed, S1P was fairly stable in cells and that SK activity was 
proportionately higher than S1PL activity in the majority of NK cells supporting an 
accumulation of S1PF. The relatively high level of SK activity in most cells suggested that a 
major subpopulation of NK cells was geared towards increased proliferation, migration, and 
cytokine production. The small population of cells with large amounts of HAF suggested 
that in some cells, the high SK activity was overcome by metabolism of S1P to shut down 
S1P signaling. These peripheral blood NK cells formed a highly heterogeneous population 
with respect to S1P production and metabolism. Since S1P is implicated in the regulation of 
NK cell migration and cytotoxicity, traits that are known to vary substantially between NK 
cells, this cell-to-cell heterogeneity may be important for the wide range of immune 
functions in which NK cells must participate.
Inter-subject comparison of the distribution of SF reporter conversion revealed similarities 
as well as subtle differences among all subjects. Overall there was a broad distribution of 
phosphorylation amongst the cells analyzed from subject 1; however, the majority of cells 
(51%) contained less than 20% S1PF with 45% of subject 1’s cells possessing less than 10% 
S1PF (Fig. 3b). The cells from subject 2 also possessed a wide range of levels of S1PF, and 
43% of the cells produced less than 10% S1PF. Thus the SF-S1PF balance in the NK cells of 
subjects 1 and 2 suggested a relatively lower level of NK cell proliferation and mobility 
relative to the average of all subjects. The majority (65%) of subject 3’s cells possessed 
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more than 50% S1PF with 30% of the cells displaying 490% S1PF suggesting that this 
individual’s NK cells might be biased towards proliferation and migration. Subject 4 also 
had a wide, fairly even, distribution of phosphorylation with the majority (57%) of cells 
possessing greater than 50% S1PF. The SF-S1PF balance in the NK cells of subjects 3 and 4 
was biased towards higher S1P production, relative to the average of all subjects, suggesting 
that these cells might have higher levels of mobility and proliferation. These results 
highlight the intercellular heterogeneity of the S1P pathway in NK cells from a single 
individual as well as the S1P signaling variability between subjects. Hierarchical clustering 
was used to compare the overall distribution of S1PF formation between the subjects (Fig. 
3d). Subjects 1 and 2 clustered together, since both possessed S1PF distributions skewed 
towards lower levels of S1PF relative to the distributions of subjects 3 and 4, which co-
clustered (Fig. 3b).
The majority of cells from all four subjects displayed low percentages of reporter conversion 
to HAF (Fig. 3c). 73%, 93%, 83%, and 81% of cells from subjects 1–4 had less than 5% 
production of HAF, respectively. 16%, 0%, 0%, and 0% of the cells from subjects 1–4 had 
greater than 25% conversion of SF to HAF. This again suggests a relatively higher activity 
for SK compared to the downstream metabolic enzymes, which may permit rapid 
accumulation of S1P and cell activation during NK-cell encounters with infected cells. Of 
note is that although subjects 1 and 2 clustered together with respect to the percentage of 
S1P formed, the two individuals differed when producing HAF. Subject 1 formed much 
greater amounts of HAF than did subject 2, suggesting that subject 1 did produce S1PF, but 
also metabolized it quickly. While the NK cells of subjects 1 and 2 both possessed low 
amounts of S1PF, the cells may have used varying mechanisms to lower the percentage of 
S1PF. These data suggest that there may be multiple layers of the S1P concentration in NK 
cells and simultaneous measurement of multiple enzymatic products is required for an 
accurate understanding of S1P signaling.
The distinct patterns of S1PF and HAF formation observed in NK cells from different 
subjects may arise from a variety of sources other than the history of viral infections. NK 
cell activity varies with body mass index (BMI), gender, age, and race, among many other 
factors.42-44 Notably, subjects 1 and 2, whose cells were skewed towards lower levels of 
S1P, were both older than subjects 3 and 4 (Table S1, ESI†). However, the sample size of 
four subjects is too small to identify the sources of variations in the phosphorylation 
distribution. Further research will be needed to identify the sources of this heterogeneity and 
determine whether age, race, or BMI are contributors to the inter-subject variability.
Sphingosine-1-phosphate phosphatase activity in NK cells
To additionally characterize the flow of metabolites in the S1P pathway, S1PF was loaded 
into cells and its fluorescent metabolites measured. A total of 41 cells were assayed, with 11 
from subject 5 and 31 from subject 6. On average, significantly less S1PF reporter (0.2 ± 0.2 
amol) was loaded into cells compared to that for the SF reporter (13 ± 35 amol) (p = 2 × 
10−6). S1PF is more polar than SF, likely creating an added barrier to traversing the 
membrane.27 17 ± 15% of cells did not load a detectable quantity of S1PF. The amount of 
S1PF reporter loaded did not correlate with the cell diameter for the combined cells from 
Dickinson et al. Page 11













subjects 5 and 6 (R2 = 0.04) or for the cells for each subject individually (Fig. 4a). For both 
subjects, the amount of reporter loaded into the cells was linearly correlated with the time 
that the reporter was incubated in the solution surrounding the cell (R2 = 0.6). This 
correlation was significant for all cells (p < 0.001), as well as for the cells from subjects 5 (p 
< 0.05) and 6 (p < 0.001), respectively (Fig. 4b). This relationship may be due to the very 
slow cellular internalization of the S1PF reporter as a result of its increased polarity or to a 
different mechanism of import into the cell. The majority of cells (95 ± 8%) that did load 
with S1PF did not convert it to any other detectable compound (Fig. 4c). None of the cells 
dephosphorylated the reporter to form SF. This result suggested that the majority of NK 
cells analyzed had very low S1PP activity in comparison to SK activity. However, the low 
levels of S1PF conversion may also be due to differences in the location of S1PF in the 
cells. The fluorescence microscopy images of S1PFloaded cells suggested that the reporter 
was distributed predominantly in the cytoplasm of the cells and with minimal amounts 
present in the nucleus (Fig. S10, ESI†). 0% and 11% of S1PF-loaded cells from subject 5 
and 6, respectively, were observed to convert the reporter to HAF, suggesting that the S1PF 
was accessible to the downstream metabolic enzymes. Again, these data suggested that in 
NK cells, the sphingosine metabolic pathways might be biased toward accumulation of S1P 
within the cells.
Conclusion
Our findings suggest that activity within the S1P pathway is highly heterogeneous in NK 
cells obtained from an individual subject as well as between different subjects. These results 
are consistent with previous studies identifying a wide variety of NK cell types thought to be 
present in humans.4,14 Differing patterns of SF reporter processing were also observed 
amongst the subjects with the cells of some subjects displaying a bias towards lower S1PF 
levels per cell and other individuals exhibiting a very broad range of S1PF levels. 
Phosphorylation of the SF reporter was upregulated relative to S1PF breakdown in the 
majority of cells, but small subpopulations of cells, mostly from one subject, demonstrated 
high metabolism of the phosphorylated reporter. This indicated that NK cells may regulate 
S1P concentrations using different mechanisms. Based on the very low levels of back 
conversion of S1PF to SF, S1PP activity in human subjects appears to be significantly lower 
than that of SK activity. Additionally, no peaks were observed on the electropherograms that 
could have been attributable to fluorescent ceramide formation, suggesting that the 
sphingosine–ceramide pathway in healthy humans is skewed to rapidly metabolize 
sphingosine to sphingosine-1-phosphate. The rapid conversion into sphingosine-1-phosphate 
would then act to favor cell proliferation and cell egress out of blood vessels into tissue as 
well as production of pro-inflammatory cytokines rather than apoptosis. All of these 
attributes would contribute towards rapid activation of the immune system toward 
pathogens.
The automated single-cell CE technology enabled the rapid assay by electrophoretic 
separation of hundreds of single cells. Sphingosine metabolism was characterized in the 
primary NK cells derived from the peripheral blood of six different humans. The high 
separation capacity of CE enabled measurement of multiple sphingolipids, permitting 
characterization of the activity of four enzymes (SK, S1PP, S1PL/FALDH). Increasing the 
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automated system’s throughput and synthesizing additional fluorescent sphingolipid 
reporters will enable simultaneous measurement of the activity of dozens of kinases and 
lipases in thousands of cells per human, providing a more comprehensive picture of each 
individual cell’s signaling pathways.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Quantification of lipid signaling in single primary human cells has been challenging due 
to the hydrophobicity of lipids, very small size of mammalian cells, and fragility of 
primary cells. An automated single-cell, capillary electrophoresis system was used to 
characterize the sphingosine pathway in primary, human NK cells. The technology 
enabled simultaneous measurement of fluorescent sphingosine-1-phosphate (S1P) and 
hexadecanoic acid (HA) formed from a fluorescein-labeled sphingosine reporter. 
Substantial heterogeneity in S1P production and metabolism across cells within and 
between subjects was readily apparent. NK-cell subpopulations may exist with respect to 
SK activity and individual humans may possess distinct phenotypes. A deeper 
understanding of lipid signaling at the single-cell level will be critical to understand NK 
cell biology and disease.
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Optimization of the automated single-cell CE system for NK cells. (a) Schematic (top view) 
of the channel system used for automated singlecell CE analysis. (b) Schematic (cross 
section) through a section of the cell traps (not drawn to scale). Surface tension prevents the 
electrophoretic (green) and physiologic (purple) buffers from spilling into the air gap. The 
orange spheres represent cells within the traps. (c) Brightfield image of an NK cell trapped 
in each of three microwells. (d) The percentage of microwells entrapping a single cell is 
shown for microwells of varying diameter. Three replicates were obtained for each 
histogram (*p ≤ 0.05; **p ≤ 0.01).
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Single-cell analysis of peripheral blood NK cells. (a) Representative electropherogram 
demonstrating separation of SF, S1PF, and U50 (HAF) from 19 cells sequentially analyzed. 
(b) An expanded region of the electropherogram shown in panel (b) demonstrating the 
contents of 5 cells. (c) The S1P pathway in NK cells. Abbreviations: ceramidase (CDase) 
and ceramide synthase (CS).
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Metabolism of SF in single NK cells. (a) A 3D plot comparing the percentage of S1PF and 
HAF formed from the total SF loaded into a cell. The lower x axis displays the total 
concentration of reporter loaded into the cell (SFmol + S1PFmol + HAFmol). (b) Histograms 
expressing the number of cells with different percentages of S1PF for each subject. (c) 
Histograms comparing the percent of reporter converted to HAF for each subject. (d) The 
tree diagram showing hierarchical clustering comparing the overall distribution of percent 
S1PF formation between subjects 1–4.
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S1PF loading and metabolism in NK cells from two subjects (n = 36 cells). (a) The total 
amount of S1PF loaded into cells (S1PFmol + HAFmol) plotted against the diameter of the 
cells. (b) The total amount of S1PF loaded into cells (S1PFmol + HAFmol) was plotted 
against the reporter exposure time. (c) The percent of S1PF and HAF formed in a cell 
(relative to the total reporter loaded) was plotted against the total amount of S1PF reporter 
loaded into that cell.
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